Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Biomedical Research and Technologies (IBRT) is a private biotechnology company and research organization based in Sofia, Bulgaria, specializing in regenerative medicine and molecular immunology. The institute focuses on the development of innovative therapies using mesenchymal stem cells (MSCs) and the study of immunomodulatory proteins such as HLA-G. IBRT's research primarily targets reproductive health, specifically addressing endometrial receptivity and recurrent pregnancy loss, as well as potential applications in oncology. In addition to its internal R&D pipeline, the institute provides specialized laboratory services and participates in numerous international scientific collaborations and EU-funded projects. Their expertise encompasses cell culture, flow cytometry, and the production of monoclonal antibodies for research and diagnostic use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Biomedical Research and Technologies.